Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Kansra, Sanjay ^a,b   Chen, Shenglin ^b   Bangaru, Madhavi Latha Yadav ^b   Sneade, Leighton ^a   Dunckley, Joseph A ^a   Ben Jonathan, Nira ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; PROLACTIN; PROTEASOME; SELECTIVE ESTROGEN RECEPTOR MODULATOR; 1,3 BIS(4 HYDROXYPHENYL) 4 METHYL 5 (4 (2 PIPERIDINYLETHOXY)PHENOL) 1H PYRAZOLE; 1,3-BIS(4-HYDROXYPHENYL)-4-METHYL-5-(4-(2-PIPERIDINYLETHOXY)PHENOL)-1H-PYRAZOLE; ANTIESTROGEN; DRUG DERIVATIVE; ESTRADIOL; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; INHIBITION KINETICS; NONHUMAN; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; PROTEIN DEGRADATION; RAT; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

RATTUS;

ANIMALS; CELL LINE; CELL PROLIFERATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; LACTOTROPHS; PIPERIDINES; PROLACTIN; PYRAZOLES; RATS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 77956333678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010060     Document Type: Article

References (26)

1. Wakeling AE, Dukes M, Bowler J (1991) A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873.
2. Dauvois S, White R, Parker MG (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106 (Pt 4): 1377-1388.
3. Fawell SE, White R, Hoare S, Sydenham M, Page M, et al. (1990) Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A 87: 6883-6887.
4. Dauvois S, Danielian PS, White R, Parker MG (1992) Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89: 4037-4041.
5. Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49-53.
6. Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, et al. (1997) Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277: 1508-1510.
7. Jensen EV, Suzuki T, Numata M, Smith S, DeSombre ER (1969) Estrogenbinding substances of target tissues. Steroids 13: 417-427.
8. Nirmala PB, Thampan RV (1995) Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. Biochem Biophys Res Commun 213: 24-31.
9. Alarid ET, Bakopoulos N, Solodin N (1999) Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol 13: 1522-1534.
10. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, et al. (2001) FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasomedependent. Nat Cell Biol 3: 15-23.
11. Dace A, Zhao L, Park KS, Furuno T, Takamura N, et al. (2000) Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci U S A 97: 8985-8990.
12. Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C (2002) Peroxisome prolifERαtor-activated receptor alpha (PPARalpha) turnover by the ubiquitinproteasome system controls the ligand-induced expression level of its target genes. J Biol Chem 277: 37254-37259.
13. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD (1995) IntERαction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374: 91-94.
14. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, et al. (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19: 1182-1189.
15. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ, Janne OA (1999) Ubc9 intERαcts with the androgen receptor and activates receptor-dependent transcription. J Biol Chem 274: 19441-19446.
16. Imhof MO, McDonnell DP (1996) Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol Cell Biol 16: 2594-2605.
17. Laios I, Journe F, Laurent G, Nonclercq D, Toillon RA, et al. (2003) Mechanisms governing the accumulation of estrogen receptor alpha in MCF-7 breast cancer cells treated with hydroxytamoxifen and related antiestrogens. J Steroid Biochem Mol Biol 87: 207-221.
18. Caporali S, Imai M, Altucci L, Cancemi M, Caristi S, et al. (2003) Distinct signaling pathways mediate stimulation of cell cycle progression and prevention of apoptotic cell death by estrogen in rat pituitary tumor PR1 cells. Mol Biol Cell 14: 5051-5059.
19. Newton CJ (1995) Estrogen blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumor cells. J Ster Biochem Mol Biol 55: 327-336.
20. Kansra S, Yamagata S, Sneade L, Foster L, Ben Jonathan N (2005) Differential effects of estrogen receptor antagonists on pituitary lactotroph prolifERαtion and prolactin release. Mol Cell Endocrinol 239: 27-36.
21. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, et al. (2003) Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206: 13-22.
22. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, et al. (2002) Antagonists selective for estrogen receptor alpha. Endocrinology 143: 941-947.
23. Yu R, Ren SG, Melmed S (2002) Proteasome inhibitors induce apoptosis in growth hormone- and prolactin-secreting rat pituitary tumor cells. J Endocrinol 174: 379-386.
24. Wong JK, Le HH, Zsarnovszky A, Belcher SM (2003) Estrogens and ICI182,780 Faslodex) modulate mitosis and cell death in immature cerebellar neurons via rapid activation of p44/p42 mitogen-activated protein kinase. J Neurosci 23: 4984-4995.
25. Steinmetz R, Gutierrez-Hartmann A, Bigsby RM, Ben-Jonathan N (1994) Activation of the prolactin promoter in transfected GH3 cells by posterior pituitary cells. Endocrinology 135: 2737-2741.
26. Ji Y, Prasad NB, Novotny EA, Kaur S, Elkahloun A, et al. (2007) Mouse embryo fibroblasts lacking the tumor suppressor menin show altered expression of extracellular matrix protein genes. Mol Cancer Res 5: 1041-1051.